United States Antimony shares rise 10.53% intraday as H.C. Wainwright raises price target to $10.25 and Q3 results show record sales.

United States Antimony (UAMY) surged 10.53% intraday, driven by a combination of upgraded analyst outlooks, strong Q3 performance, and a major supply agreement. H.C. Wainwright raised its price target to $10.25 with a "Buy" rating, while William Blair revised FY2027–FY2029 EPS forecasts higher, signaling long-term optimism. The company’s Q3 2025 earnings highlighted record sales and strategic positioning in U.S. defense/energy supply chains, reinforcing its growth narrative. Additionally, a $106 million domestic antimony supply contract, announced on November 11, underscored operational momentum and demand for critical minerals. Although William Blair trimmed Q4 2025 and FY2026 EPS estimates, near-term concerns were overshadowed by bullish long-term signals and the contract’s implications for sustained revenue. The rally reflects investor confidence in UAMY’s strategic positioning and analyst-driven valuation upgrades despite mixed short-term guidance.